Abstract
S78 the HSCT diagnosis or date of hospitalization (control group) were assessed in a blinded fashion using a standardized scoring system (14). Results: A total of 125 patients were enrolled in the study. 76 (60.8%) of the patients were male and 49 (39.2%) were female. The median level of pre-transplant serum ferritin was 1023.00 ng/mL (min-max: 393.80-1627.50). The majority of the patients were diagnosed with acute leukemia (83, 66.4%) and lymphomas (20, 16.0%). The median day for neutrophil engraftment was 14.00(minmax:13.00-16.00) days and 11.00 (min-max:10.00-14.00) days for platelet engraftment. 50 patients (40.0%) was died to primary disease or secondary complications (infection, bleeding) during post-transplant follow-up. Conclusion: The validation of BMIS for risk stratification in patients who undergo allogeneic hematopoietic stem cell transplantation may predict posttransplant outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
